YTHDF2 and acute myeloid leukemia: Numerous studies have shown that methyltransferase complex components (METTL3, METTL14, WTAP), demethylases (FTO, ALKBH5), and the m6A binding protein (YTHDF2, YTHDC1, and IGF2BPs) are all highly expressed in AML.